Cardinal Health, Inc.
CAH · NYSE
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B |
| Cost of Revenue | $244.47B | $214.41B | $219.41B | $198.10B | $174.84B | $155.69B | $146.05B | $138.70B |
| Gross Profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B |
| Selling, General & Administrative | $6.13B | $5.38B | $5.00B | $4.80B | $4.51B | $4.53B | $4.57B | $4.48B |
| Operating Income | $2.61B | $2.27B | $1.24B | $752.00M | -$607.00M | $472.00M | -$4.10B | $2.06B |
| Interest Expense | $348.00M | $215.00M | $51.00M | $84.00M | $147.00M | $180.00M | $238.00M | $294.00M |
| Other Income / (Expense) | $31.00M | $41.00M | $9.00M | -$5.00M | -$22.00M | $47.00M | $1.00M | -$15.00M |
| Income Before Taxes | $2.17B | $2.10B | $1.20B | $663.00M | -$784.00M | $323.00M | -$3.77B | $1.75B |
| Provision for Income Taxes | $469.00M | $532.00M | $348.00M | $332.00M | $153.00M | -$289.00M | -$79.00M | $386.00M |
| Net Income | $1.71B | $1.56B | $852.00M | $330.00M | -$938.00M | $611.00M | -$3.70B | $1.36B |
| Basic EPS | $7.27 | $6.48 | $3.48 | $1.27 | -$3.37 | $2.09 | -$12.61 | $4.55 |
| Diluted EPS | $7.23 | $6.45 | $3.45 | $1.26 | -$3.37 | $2.08 | -$12.61 | $4.53 |
| Basic Shares Outstanding | 236.00M | 241.00M | 245.00M | 261.00M | 279.00M | 292.00M | 293.00M | 300.00M |
| Diluted Shares Outstanding | 237.00M | 242.00M | 247.00M | 262.00M | 279.00M | 294.00M | 293.00M | 301.00M |
Analyst Estimates
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jun 2026 | $10.77 | $10.74 | $10.81 | 9 | ↑2 ↓0 |
| Jun 2027 | $12.55 | $12.51 | $12.60 | 9 | ↑1 ↓0 |
| Jun 2028 | $13.91 | $13.15 | $14.15 | 7 | ↑1 ↓1 |
| Jun 2029 | $15.18 | $14.59 | $15.62 | 5 | ↑0 ↓0 |
| Jun 2030 | $17.48 | $17.48 | $17.48 | 1 | ↑0 ↓0 |
